Paricalcitol

Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.

Cross Reference

Introduction

To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Paricalcitol?

Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Paricalcitol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Paricalcitol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Paricalcitol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What genes are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Paricalcitol

Download all related citations
Per page 10 20 50 100 | Total 375
Authors Title Published Journal PubMed Link
Hansen D A randomised clinical study of alfacalcidol and paricalcitol. 2012 Dan Med J pmid:22293059
Martin KJ and González EA Long-term management of CKD-mineral and bone disorder. 2012 Am. J. Kidney Dis. pmid:22520454
Cozzolino M et al. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 2012 Nephrol. Dial. Transplant. pmid:22523119
Fish RS and Cunningham J FGF-23 and vitamin D: don't shoot the messenger? 2012 Nephrol. Dial. Transplant. pmid:22523113
Thadhani R et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. 2012 JAMA pmid:22337679
Anker SD and von Haehling S Vitamin D in chronic kidney disease: more questions than answers. 2012 JAMA pmid:22337683
Cozzolino M et al. Role of vitamin d receptor activators in cardio-renal syndromes. 2012 Semin. Nephrol. pmid:22365164
Park JW et al. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. 2012 Eur. J. Pharmacol. pmid:22449373
Tonbul HZ et al. Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study. 2012 Ren Fail pmid:22251408
Piao SG et al. Protective effect of paricalcitol on cyclosporine-induced renal injury in rats. 2012 Transplant. Proc. pmid:22483459